02.19.15 | 7:07 PMShare 0
Pin 0
Email
The Nasdaq rose for the seventh straight session, driven by biotech stocks. The Composite getting closer to the 5,000 mark. But stocks mostly ended in the red zone amid uncertainty over the prospectsShare 0
Pin 0
Link:
Nasdaq Up for Seventh Straight Session
[…]
Benchmarks ended mostly lower on Wednesday after Fed minutes showed officials debated the effects of hiking interest rates from near zero level. While “many” officials said premature rise in interest rates will hamper U.S. economic recovery, “several” officials opined delaying the same will result in high inflation. Meanwhile, a drop in oil prices dragged energy shares down. While the S&P […]
Hey, I see you sitting there at your computer like a wimp, with your pumpkin spice latte and lilac crème crepe. Put ‘em away.It’s time to get to work…Today you’re hopping on a good ole fashioned steamroller for an honest day’s pay. Your job is to turn every underperforming industry and market sector into pancakes…So grab your lunch pail, put […]
After trending downwards for the last year, the Nasdaq Internet Group finally looks to be breaking higher. You can see the break above the top of the downtrend in the chart below.Remember when the Internet group was surging higher right inline with the Biotech group in 2013? That surge seems like an eternity ago after the lackluster performance Internet stocks […]
Stocks closed mixed Tuesday, lead by large cap indexes. Trading volume was light as we continue to chug-along here near highs. Biotechs were back to their winning ways as the Nasdaq Biotech index nears all time highs. Leading stocks generally outperformed, albeit by a smaller margin. CYBR extended it’s earnings related gains, yet VDSI swung wildly after announcing it’s earnings. […]
View gallery.Preface: The biotech stocks considered for this review were confined to those over $10 per share that traded at least 500K shares a day based on a 90-day average.For the longest time it seemed that for every new high the S&P 500 hit, biotech stocks, as measured by the iShares Nasdaq Biotechnology Index (NASDAQ: IBB), hit two new […]
Preface: The biotech stocks considered for this review were confined to those over $10 per share that traded at least 500K shares a day based on a 90-day average.For the longest time it seemed that for every new high the S&P 500 hit, biotech stocks, as measured by the iShares Nasdaq Biotechnology Index (NASDAQ: IBB), hit two new highs.Biotechnology […]
Benchmarks closed at record highs on Friday after higher oil prices boosted energy shares. While the S&P 500 closed at an all-time record high, the Dow ended above the 18K mark for the first time this year. The Nasdaq hit a 15-year high, boosted by gains in technology stocks. Friday’s gains helped benchmarks settle in positive territory for the second-straight […]
In a repeat of a dynamic that dominated trading early last year, investors piled into stocks Thursday as Russia signed up for another cease-fire deal in Ukraine while negotiations between Greece and the European establishment suddenly became less acrimonious. While no deal has been announced, the bureaucrats have been making noises about agreeing to the outlines of an agreement which, […]
Biotechnology indices have been on a rapid ascent for three years, and 2015 appears to be off to the races as well. Bloom Burton & Co.’s David Martin has taken his seat in the grandstands, betting on specialty pharma and one day delivery cialis biotech companies based in Canada, where resource stocks have absorbed so much investment capital that […]
